These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28185577)

  • 61. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signature.
    Scaruffi P; Morandi F; Gallo F; Stigliani S; Parodi S; Moretti S; Bonassi S; Fardin P; Garaventa A; Zanazzo G; Pistoia V; Tonini GP; Corrias MV
    Pediatr Blood Cancer; 2012 Jul; 59(1):44-51. PubMed ID: 21994039
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients.
    Morandi F; Corrias MV; Levreri I; Scaruffi P; Raffaghello L; Carlini B; Bocca P; Prigione I; Stigliani S; Amoroso L; Ferrone S; Pistoia V
    Cancer Immunol Immunother; 2011 Oct; 60(10):1485-95. PubMed ID: 21660451
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transcriptional adaptation of neuroblastoma cells to hypoxia.
    Fredlund E; Ovenberger M; Borg K; Påhlman S
    Biochem Biophys Res Commun; 2008 Feb; 366(4):1054-60. PubMed ID: 18155155
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome.
    Raggi CC; Maggi M; Renzi D; Calabrò A; Bagnoni ML; Scaruffi P; Tonini GP; Pazzagli M; De Bernardi B; Bernini G; Serio M; Orlando C
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3866-73. PubMed ID: 11061551
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of 2 putative critical segments of 17q gain in neuroblastoma through integrative genomics.
    Vandesompele J; Michels E; De Preter K; Menten B; Schramm A; Eggert A; Ambros PF; Combaret V; Francotte N; Antonacci F; De Paepe A; Laureys G; Speleman F; Van Roy N
    Int J Cancer; 2008 Mar; 122(5):1177-82. PubMed ID: 17973261
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tumor classification by combining PNN classifier ensemble with neighborhood rough set based gene reduction.
    Wang SL; Li X; Zhang S; Gui J; Huang DS
    Comput Biol Med; 2010 Feb; 40(2):179-89. PubMed ID: 20044083
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes.
    Warnat P; Oberthuer A; Fischer M; Westermann F; Eils R; Brors B
    BMC Cancer; 2007 May; 7():89. PubMed ID: 17531100
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A 36-gene signature predicts clinical progression in a subgroup of ERG-positive prostate cancers.
    Gasi Tandefelt D; Boormans JL; van der Korput HA; Jenster GW; Trapman J
    Eur Urol; 2013 Dec; 64(6):941-50. PubMed ID: 23490727
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system.
    Stricker TP; Morales La Madrid A; Chlenski A; Guerrero L; Salwen HR; Gosiengfiao Y; Perlman EJ; Furman W; Bahrami A; Shohet JM; Zage PE; Hicks MJ; Shimada H; Suganuma R; Park JR; So S; London WB; Pytel P; Maclean KH; Cohn SL
    Mol Oncol; 2014 May; 8(3):669-78. PubMed ID: 24560446
    [TBL] [Abstract][Full Text] [Related]  

  • 71. GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma.
    Ho WL; Chou CH; Jeng YM; Lu MY; Yang YL; Jou ST; Lin DT; Chang HH; Lin KH; Hsu WM; Huang MC
    Oncotarget; 2014 Dec; 5(23):12247-59. PubMed ID: 25362349
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN.
    Cohn SL; London WB; Huang D; Katzenstein HM; Salwen HR; Reinhart T; Madafiglio J; Marshall GM; Norris MD; Haber M
    J Clin Oncol; 2000 Nov; 18(21):3604-13. PubMed ID: 11054433
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Integration of molecular features with clinical information for predicting outcomes for neuroblastoma patients.
    Han Y; Ye X; Wang C; Liu Y; Zhang S; Feng W; Huang K; Zhang J
    Biol Direct; 2019 Aug; 14(1):16. PubMed ID: 31443736
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma.
    Maggio V; Chierici M; Jurman G; Furlanello C
    PLoS One; 2018; 13(12):e0208924. PubMed ID: 30532223
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of sulfasalazine on human neuroblastoma: analysis of sepiapterin reductase (SPR) as a new therapeutic target.
    Yco LP; Geerts D; Mocz G; Koster J; Bachmann AS
    BMC Cancer; 2015 Jun; 15():477. PubMed ID: 26093909
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epigenome-wide association study reveals CpG sites related to COG of neuroblastoma.
    Zhao H; Zhou X; Sun H; Zhao D; Liu H; Huang B; Li X; Gu Y
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32378698
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Two independent epigenetic biomarkers predict survival in neuroblastoma.
    Yáñez Y; Grau E; Rodríguez-Cortez VC; Hervás D; Vidal E; Noguera R; Hernández M; Segura V; Cañete A; Conesa A; Font de Mora J; Castel V
    Clin Epigenetics; 2015; 7(1):16. PubMed ID: 25767620
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of multiple hypoxia signatures in neuroblastoma cell lines by l1-l2 regularization and data reduction.
    Fardin P; Cornero A; Barla A; Mosci S; Acquaviva M; Rosasco L; Gambini C; Verri A; Varesio L
    J Biomed Biotechnol; 2010; 2010():878709. PubMed ID: 20652058
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The roles of microRNAs in neuroblastoma.
    Mei H; Lin ZY; Tong QS
    World J Pediatr; 2014 Feb; 10(1):10-6. PubMed ID: 24464658
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differentiation in neuroblastoma: diffusion-limited hypoxia induces neuro-endocrine secretory protein 55 and other markers of a chromaffin phenotype.
    Hedborg F; Fischer-Colbrie R; Ostlin N; Sandstedt B; Tran MG; Maxwell PH
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.